Intensivmedizin up2date, Table of Contents Intensivmedizin up2date 2015; 11(01): 2-3DOI: 10.1055/s-0034-1390977 Ask the Expert © Georg Thieme Verlag KG Stuttgart · New YorkFrage zur Lyseindikation bei Lungenembolie S. Konstantinides Recommend Article Abstract All articles of this category Full Text References Literatur 1 Meyer G, Vicaut E, Danays T et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370: 1402-1411 2 Interdisziplinäre S2-Leitlinie. Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie. Vasa 2010; 39 (Suppl. 78) 1-39 3 Sharifi M, Bay C, Skrocki L et al. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 2013; 111: 273-277 4 Wang C, Zhai Z, Yang Y et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 2010; 137: 254-262 5 Kucher N, Boekstegers P, Muller OJ et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129: 479-486
